UNSPSC 51383501: Tenidap

This classification denotes a non-steroidal anti-inflammatory agent and cyclooxygenase inhibitor with the molecular formula C14H9ClN2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9K7CJ74ONH, chemically known as 2,3-dihydro-5-chloro-2-oxo-3-(2-thienylcarbonyl)-1h-indole-1-carboxamide but generally known as tenidap, which bears US NIH Compound Identifier 57946. European Medicines Agency schedules Tenidap in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15484MIG.

UNSPSC 51383501 Tenidap, a Commodity code, does not match the work actually being solicited under this code designation. The single recent state-and-local opportunity tagged to it — Seminole County, Florida's procurement of naloxone and drug deactivation systems — represents emergency-response supplies and public-health equipment, not pharmaceutical active ingredients or formulations. Tenidap is a nonsteroidal anti-inflammatory drug; the Seminole County solicitation involves overdose-reversal medication and harm-reduction equipment with no connection to that therapeutic category or chemical compound.

The mismatch suggests either a cataloging error in the state or local procurement system or a systematic misalignment between UNSPSC assignment and actual commodity classification. No other recent opportunities appear in the activity record under this code. Business development professionals should treat this code as showing little relevant recent activity in state and local procurement and verify the correct UNSPSC designation for pharmaceutical supply chains or overdose-response equipment before allocating pursuit resources.